- Trials with a EudraCT protocol (34)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
34 result(s) found for: Innate Immune System.
Displaying page 1 of 2.
EudraCT Number: 2021-004573-32 | Sponsor Protocol Number: 21-05 | Start Date*: 2021-10-05 |
Sponsor Name:Centre Hospitalier Annecy Genevois | ||
Full Title: Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) versus Standard-Dose (QIV-SD), in subjects 65 years of age and older on innate immunity, including gene expression. | ||
Medical condition: Healthy volunteers (influenza vaccination) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001357-31 | Sponsor Protocol Number: IIV-478 | Start Date*: 2021-05-03 |
Sponsor Name:National Institute of Health and the Environment | ||
Full Title: Immune Responses Induced by Vaccination Against COVID-19 in Dutch healthy subjects | ||
Medical condition: Immune Responses Induced by Vaccination Against COVID-19 in Dutch healthy subjects | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002781-12 | Sponsor Protocol Number: 2019061567 | Start Date*: 2021-08-05 | ||||||||||||||||
Sponsor Name:University of Southern Denmark, Bandim Health Project | ||||||||||||||||||
Full Title: Using BCG vaccine to strengthen the immune system in the elderly and improve the response to influenza vaccine. A randomized clinical trial. | ||||||||||||||||||
Medical condition: Immune response to seasonal influenza vaccine | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005860-24 | Sponsor Protocol Number: OmniaOMS | Start Date*: 2022-10-28 | |||||||||||
Sponsor Name:I.R.C.C.S. FONDAZIONE S.LUCIA | |||||||||||||
Full Title: Multidimensional integrated assessment of neurological and immunological patterns to test the efficacy and response to Ozanimod in multiple sclerosis | |||||||||||||
Medical condition: relapsing remitting multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000116-42 | Sponsor Protocol Number: BioVacSafe-QIV | Start Date*: 2017-03-02 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: A clinical study of biomarkers of innate and adaptive immune activation associated with symptoms and immune responses after administration of a single dose of a quadrivalent inactivated split virus... | |||||||||||||
Medical condition: Healthy Volunteers - a quadrivalent inactivated split virus influenza vaccine | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003673-18 | Sponsor Protocol Number: 1062016 | Start Date*: Information not available in EudraCT |
Sponsor Name:UZ Brussel | ||
Full Title: Can we with vitamin D3, improve the innate immune system? | ||
Medical condition: Immunological problems such as hypogammaglobulinemia with clinical recurrent infections such as sinusitis , pneumonia , otitis , skin infections and gastrointestinal infections. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003543-35 | Sponsor Protocol Number: BioVacSafe–FluadTM | Start Date*: 2014-09-23 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: A clinical study to generate a set of data characterising clinical events, physiological responses, and innate and adaptive immune responses following a single intramuscular immunisation with Fluad... | |||||||||||||
Medical condition: vaccin against influenza | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001450-22 | Sponsor Protocol Number: MESCEL-COVID19 | Start Date*: 2020-04-29 | |||||||||||
Sponsor Name:Fundación de Investigación del Hospital Infantil Universitario Niño Jesús | |||||||||||||
Full Title: Phase II Clinical Trial to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe pulmonary involvement by COVID-19. | |||||||||||||
Medical condition: Severe pulmonary involvement by COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004455-29 | Sponsor Protocol Number: 112115 | Start Date*: 2008-12-05 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, randomized, multicentre, observer-blind study to compare and characterize the immunoginicity and safety parameters induced by various GSK Biologicals’ Adjuvant Systems in combination wi... | ||
Medical condition: Hepatitis B surface antigen (HBsAg) vaccine administred in HBV naïve adult subjects aged between 18 and 45 years old, inclusive, in good general health. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001344-22 | Sponsor Protocol Number: 116640 | Start Date*: 2013-02-19 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, randomised, single-blind study to develop read-outs aimed at detecting and characterising the early and adaptive immune responses and to evaluate the kinetics of the early response and ... | ||
Medical condition: Healthy volunteers (Hepatitis B surface antigen (HBsAg) vaccine administered in hepatitis B virus (HBV) naive adult subjects aged between 18 and 45 years old, inclusive, in good general health.) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-005520-42 | Sponsor Protocol Number: BCG-LPS | Start Date*: 2014-04-28 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: The effects of BCG-vaccination on the innate immune response and immunoparalysis in healthy volunteers | |||||||||||||
Medical condition: sepsis induced immunoparalysis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005687-97 | Sponsor Protocol Number: NoSIRS | Start Date*: 2013-06-20 |
Sponsor Name:Medtronic Inc. | ||
Full Title: Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a pilot study | ||
Medical condition: Possible future indications: inflammatory conditions in general | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002879-14 | Sponsor Protocol Number: BioVacSafe-Boostrix® | Start Date*: 2015-07-30 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: BioVacSafe-Boostrix®: een klinische studie om een reeks gegevens te regenereren die kenmerkend zijn voor klinische gebeurtenissen, fysiologische reacties en aangeboren en adaptieve immuunreacties v... | |||||||||||||
Medical condition: vaccin against diphtheria, tetanus and pertussis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005600-28 | Sponsor Protocol Number: EBI-CABG | Start Date*: 2016-06-17 |
Sponsor Name:Exponential Biotherapies Inc. | ||
Full Title: Randomized double blind placebo-controlled phase II study on the effects of EA-230 on the innate immune response following on-pump cardiac surgery | ||
Medical condition: Systemic inflammatory respons (SIRS) and associated acute kidney injury (AKI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002706-36 | Sponsor Protocol Number: VASOPRESSOR-LPS | Start Date*: 2016-01-06 |
Sponsor Name:Radboudumc | ||
Full Title: The effects of different vasopressors on the innate immune response during experimental human endotoxemia, a pilot proof-of-principle study | ||
Medical condition: Possible future indications: infectious diseases which require vasopressor therapy. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004567-11 | Sponsor Protocol Number: 75911 | Start Date*: 2020-12-08 | |||||||||||
Sponsor Name:Zealand University Hospital | |||||||||||||
Full Title: Effect of Low-dose Interferon-alfa2a on peri operative immune suppression | |||||||||||||
Medical condition: pMMR Colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002481-78 | Sponsor Protocol Number: EBI-EA230-LPS-2014 | Start Date*: 2014-10-07 |
Sponsor Name:Exponential Biotherapies Inc | ||
Full Title: Randomized double blind placebo-controlled clinical safety, tolerability and pharmacokinetic/-dynamic study on the effects of escalating single intravenous doses of EA-230 on the innate immune resp... | ||
Medical condition: Systemic inflammatory respons (SIRS) and associated acute kidney injury (AKI) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004376-18 | Sponsor Protocol Number: ANRSHB07 | Start Date*: 2021-06-10 | |||||||||||
Sponsor Name:Inserm ANRS | |||||||||||||
Full Title: ANRS HB07 IP-cure-B proof of concept (PoC) clinical trial. Educating the liver immune environment through TLR8 stimulation followed by NUC discontinuation | |||||||||||||
Medical condition: Chronic Hepatitis B virus (HBV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003250-41 | Sponsor Protocol Number: 1 | Start Date*: 2015-09-15 | |||||||||||
Sponsor Name:Public Health England | |||||||||||||
Full Title: Protection induced by Live Attenuated Influenza Vaccine (LAIV or Fluenz Tetra) - applied epidemiological study | |||||||||||||
Medical condition: There is no medical condition associated with this trial. The trial involves vaccination of healthy children with a licensed product according to the SmPC. The vaccination is Fluenz Tetra, a live... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004285-34 | Sponsor Protocol Number: STH20370 | Start Date*: 2019-01-18 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: The impact of aspirin dose modification on the innate immune response - WILL lOWer dose aspirin Therapy ReducE the response to Endotoxin? – (WILLOW TREE) | |||||||||||||
Medical condition: Acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.